Print Page   |   Sign In   |   Create a Profile
News & Press: Industry News

Opinion Piece: Our Response to the Opioid Epidemic Needs a Dose of Innovation

Wednesday, February 14, 2018   (0 Comments)
Posted by: Maria Thacker
Share |

By Jeremy Levin February 14, 2018

The opioid epidemic is the worst public health crisis in a generation. Millions of individuals, families and communities have been impacted. We need new ideas to help strengthen the calls for action by policymakers and health experts to address this growing national emergency.

Fortunately, if we are willing to learn from past experiences, we can first blunt and then end this crisis. In the 1980s, the United States faced the devastating health crisis of HIV/AIDS. But by marshaling resources and ingenuity, the nation contained and rolled back the worst effects of this crisis.

Those who lived during that period will remember the pain and fear felt by so many as reports of this deadly virus surfaced in one community after another.

America’s biopharmaceutical community went to work. Joined by patient advocates, as well as researchers in university laboratories supported by partners at the state and federal levels, we embarked on a determined search for a cure.


Dr. Jeremy Levin is chairman and CEO of Ovid Therapeutics, and chairs a working group formed by the Biotechnology Innovation Organization that has studied and developed policy solutions to address the opioid epidemic.


more Calendar

Swings Fore STEM Golf Outing 2018

Boehringer-Ingelheim Industry Tour

Membership Software Powered by YourMembership  ::  Legal